(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.36% ¥ 5 210.00
Live Chart Being Loaded With Signals
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia...
Stats | |
---|---|
Объем за сегодня | 31 600.00 |
Средний объем | 32 446.00 |
Рыночная капитализация | 177.95B |
EPS | ¥0 ( 2024-02-07 ) |
Дата следующего отчета о доходах | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥215.00 ( 2022-09-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 23.75 |
ATR14 | ¥4.73 (0.09%) |
Объем Корреляция
Noevir Holdings Co., Ltd. Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Noevir Holdings Co., Ltd. Корреляция - Валюта/Сырье
Noevir Holdings Co., Ltd. Финансовые показатели
Annual | 2023 |
Выручка: | ¥62.55B |
Валовая прибыль: | ¥42.56B (68.05 %) |
EPS: | ¥224.64 |
FY | 2023 |
Выручка: | ¥62.55B |
Валовая прибыль: | ¥42.56B (68.05 %) |
EPS: | ¥224.64 |
FY | 2022 |
Выручка: | ¥61.14B |
Валовая прибыль: | ¥42.09B (68.84 %) |
EPS: | ¥222.18 |
FY | 2021 |
Выручка: | ¥51.27B |
Валовая прибыль: | ¥33.03B (64.42 %) |
EPS: | ¥186.87 |
Financial Reports:
No articles found.
Noevir Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥215.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥36.00 | 2010-09-15 |
Last Dividend | ¥215.00 | 2022-09-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥1 556.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.4 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.40 | |
Div. Directional Score | 9.20 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9434.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8086.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7416.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6632.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5958.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4659.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
3896.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
3116.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2002.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9997.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.119 | 1.500 | 7.62 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.105 | 1.200 | 6.52 | 7.82 | [0 - 0.3] |
returnOnEquityTTM | 0.152 | 1.500 | 9.42 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 1.002 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 3.96 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.20 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.918 | 1.500 | 0.454 | 0.681 | [0.2 - 2] |
debtRatioTTM | 0.0124 | -1.500 | 9.79 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11 230 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0193 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.679 | 1.000 | 2.01 | 2.01 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.178 | 1.000 | 8.43 | 8.43 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.33 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.878 | 0.800 | 7.48 | 5.99 | [0.5 - 2] |
Total Score | 10.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.73 | 1.000 | 7.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.152 | 2.50 | 9.63 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.22 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.002 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 1.256 | 1.500 | 4.96 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.146 | 1.000 | 8.84 | 0 | [0.1 - 0.5] |
Total Score | 7.40 |
Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparels and aircrafts. The company also produces and sells toiletries; purchases and sells makeup products and vessels; and provides market research services. In addition, it provides air transportation, charter flights, ground handling, and hanger rental services; and aircraft flight training, as well as undertakes aviation-related operations. The company sells its products through drug stores, specialty goods and general merchandise stores, supermarkets, online stores, and convenience stores, as well as approximately 2,000 Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа